Targeting of interferon to choroidal neovascularization by use of dextran and metal coordination

Investigative Ophthalmology and Visual Science

Volumn 43, Issue 3, 2002, Pages 842-848

  Yasukawa, Tsutomu ^a   Kimura, Hideya ^a   Tabata, Yasuhiko ^a   Kamizuru, Hiroshi ^a   Miyamoto, Hideki ^a   Honda, Yoshihito ^a   Ogura, Yuichiro ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BETA INTERFERON; COORDINATION COMPOUND; DEXTRAN; GELATIN; METAL COMPLEX; PENTETIC ACID DERIVATIVE; SODIUM CHLORIDE; ZINC DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CONJUGATION; DRUG EFFECT; DRUG TARGETING; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ANGIOGRAPHY; HISTOLOGY; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; NONHUMAN; PIGMENT EPITHELIUM; PLASMA HALF LIFE; PRIORITY JOURNAL; RABBIT; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME;

ANGIOGENESIS INHIBITORS; ANIMALS; CATTLE; CELL DIVISION; CELLS, CULTURED; CHOROIDAL NEOVASCULARIZATION; DEXTRANS; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; HUMANS; INJECTIONS, INTRAVENOUS; INTERFERON-BETA; PENTETIC ACID; PIGMENT EPITHELIUM OF EYE; RABBITS; UMBILICAL VEINS;

EID: 0036184270     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Age-related macular degeneration and blindness due to neovascular maculopathy
2. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration: Updated findings from two clinical trials
3. Evaluation of argon green vs krypton red laser for photocoagulation of subfoveal choroidal neovascularization in the macular photocoagulation study
4. Laser photocoagulation for juxta foveal choroidal neovascularization: Five-year results from randomized clinical trials
5. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration
6. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: The influence of initial lesion size and initial visual acuity
7. The influence of treatment extent on the visual acuity of eyes treated with krypton laser for juxta foveal choroidal neovascularization
8. Visual results after surgical removal of subfoveal choroidal neovascular membranes
9. Long-term outcomes after the surgical removal of advanced subfoveal neovascular membranes in age-related macular degeneration
10. Radiation therapy for ocular choroidal neovascularization (phase I/II study): Preliminary report
11. Treatment of age-related subfoveal neovascular membranes by teletherapy
12. Visual acuity and scar size in eyes with age-related subfoveal choroidal neovascular lesions, 30 months after radiation therapy
13. Neovascular age-related macular degeneration present and future treatment options
14. Photodynamic therapy in the treatment of subfoveal choroidal neovascularisation
15. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: Two-year results of 2 randomized clinical trials-tap report 2
16. Photodynamic therapy with verteporfin for age-related macular degeneration
17. Choroidal damage caused by the excision of choroidal neovascularization
18. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
19. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470)
20. TNP-470 (AGM-1470): Mechanisms of action and early clinical development
21. Inhibition of cell motility by interferon
22. Thalidomide is an inhibitor of angiogenesis
23. Results of the Age-Related Macular Degeneration and Thalidomide Study (AMDATS) [ARVO Abstract]
24. Interferon Alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration: Results of a prospective randomized placebo-controlled clinical trial
25. Recurrence of a choroidal neovascular membrane in a patient with punctate inner choroidopathy treated with daily doses of thalidomide
26. Limitation of radiolabeled monoclonal antibodies for localization of human neoplasms
27. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
28. Electric charge influence of dextran derivatives on their tumor accumulation after intravenous injection
29. Tumor accumulation of poly(vinyl alcohol) of different sizes after intravenous injection
30. Development of a novel polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate with anionic charge. I: Physicochemical characteristics and in vivo antitumor activity
31. Development of a novel polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate with anionic charge. II: Disposition and pharmacokinetics following intravenous and intramuscular administration
32. Disposition and tumor localization of mitomycin C-dextran conjugates in mice
33. The effects of chronic cervical lymphostasis on regions drained by lymphatics and by prelymphatics
34. Targeted delivery of anti-angiogenic agent TNP-470 using water-soluble polymer in the treatment of choroidal neovascularization
35. Liver targeting of interferon through pullulan conjugation
36. Chemical conjugation of interferon with pullulan and its antiviral activity
37. Metal chelate affinity chromatography: A new approach to protein fractionation
38. Purification of protein by IMAC
39. Targeting of tumor necrosis factor to tumor by use of dextran and metal coordination
40. Simple mixing of IFN with a polysaccharide having high liver affinity enables IFN to target to the liver
41. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT
42. A new model of subretinal neovascularization in the rabbit
43. Ocular pharmacokinetics
44. Fas ligand (CD95 ligand) controls angiogenesis beneath the retina
45. Polysaccharides in oxygen-carrier blood substitutes
46. Angiography of fluoresceinated anti-vascular endothelial growth factor antibody and dextrans in experimental choroidal neovascularization
47. Oral zinc and the second eye in age-related macular degeneration
48. 3+-diethylenetriaminepentaacetic acid and dextran. 2: Influence of spacer arm length and conjugate molecular mass on the paramagnetic properties and some biological parameters